Navigation Links
Bypassing open heart bypass surgery...

A breakthrough in the treatment of coronary artery disease promises to reduce the need for open heart bypass surgery. Medical research has come up with a drug-coated stent which once inserted after clearing a clogged artery has shown an ability to check the recurrence of blockages, a common problem with the angioplasty procedure.//

The results of this new procedure, based on a scientific study, were presented at the annual meeting of the European Society of Cardiology on Wednesday. The study, which selected over 100 patients spread over Europe and South America, has shown a zero incidence of recurrence of blockage with the use of the stent, which is basically a metal mesh which props open a narrowing artery.

According to Dr Upendra Kaul, Cardiologist, and one of the pioneers of non-surgical heart procedures, that this is as important a finding as the first case of angioplasty. It should allow cardiologists to do all kinds of complex cases, earlier left for bypass surgery,'' he said, while describing the development as ``thrilling''.

This would mean that patients who were earlier not considered for angioplasty such as those who are diabetic, or have a blockage in more than one artery or whose blocking lesions are long can now be treated with this method. ``Even patients with mild forms of angina (narrowing of arteries with no heart attack) can now undergo this procedure without having to bear recurrent episodes of pain,'' Kaul says.

Surgeons, however, temper this excitement with caution. Indian arteries are narrower than the western population. The number of diabetics are much more as well, who face the risk of recurring blockages,'' says well-known cardiac surgeon, Dr Naresh Trehan. Most of all, he says, ``apart from the clear indications necessary for a surgery, the personal economics of a patient and his interest has to be kept in mind''.

Unlike western nations, in India the cost of angioplasty and surgery are almost the same due to the high cost of the stent, he said. Some cardiologists also question the long-term effects as well as effective drug delivery on the required site.

While stents have been used for several years now, a recurrence of blockage has been a common problem. Medically known as restenosis, it occurs in a large number of patients within six to eight weeks of the procedure. It is basically the body's reaction following the trauma of the medical procedure. In other words, it is like a big scar. But as it restricts blood flow, it needs to be removed. Several methods were tried in the past to stop this but with little success. However, with the use of a drug, Rapamycine, essentially used to treat rejection following an organ transplant, researchers did not find even a single case of restonsis even six months after the procedure.

The drug, says Dr Kaul, takes about three to six weeks to disappear from its site of location. But by then, the body's initial response to healing has been checked and clot formation stopped, he adds.


'"/>




Related medicine news :

1. Starvation in pregnant women can cause heart disease to their children
2. Individuals with sleep related breathing disorders more prone to heart disease
3. And now they say infections can cause heart disease!!!!
4. And now they say infections can cause heart disease!!!!
5. Award for TTK Chitra heart valve prosthesis
6. Eat greens to have a ever green heart
7. Asthma! A new warning for heart disease
8. Protein in urine foresees heart disease
9. One...just one cigarette can spoil the heart function.
10. Risk of heart disease begins in teens
11. Beer vitamin protects heart
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is ... KLS is a longtime supporter of the event. , "We are pleased that ... said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... “Doping in Sport: How the Culture Might Change,” in conjunction with ... symposium will be held at Pepperdine University in Malibu, California. , Sir Philip ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... pre-eminent publication and community for those in the fight against cancer, has produced ... in their success. HRA will release top-line findings in a webinar, Defining ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Curemark, LLC ... safety and efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling ... sites already enrolling children across the United States. , “There are currently no ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and athletics. It’s enough to overwork even the sharpest brain. , Power On, ... peak healthy activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... SEOUL , Südkorea, 23. Februar 2017 ... LED für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache ... kurzwellige ultraviolette Strahlung im Bereich zwischen 200 und 280 nm ... Ausbreitung von Bakterien, indem es ihre DNA zerstört. Das ... 280 nm. ...
(Date:2/23/2017)... , 23. Februar 2017 Im Rahmen ... nationale Wirtschaftszone in der südwestlichen chinesischen Provinz Guizhou, 2017 mit ... einer Innovationsplattform aktiv an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. ... Continue Reading ... ...
Breaking Medicine Technology: